Patents by Inventor Christopher CUTIE

Christopher CUTIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE
    Publication number: 20230321129
    Abstract: Provided are methods of treating urothelial carcinomas of the lower tract comprising administering comprising administering gemcitabine continuously and locally to the bladder of an individual in an induction therapy and/or maintenance therapy.
    Type: Application
    Filed: March 9, 2023
    Publication date: October 12, 2023
    Inventors: Dennis GIESING, Christopher CUTIE
  • METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITABINE
    Publication number: 20210085705
    Abstract: Provided are methods of treating urothelial carcinomas of the lower tract comprising administering comprising administering gemcitabine continuously and locally to the bladder of an individual in an induction therapy and/or maintenance therapy.
    Type: Application
    Filed: September 2, 2020
    Publication date: March 25, 2021
    Inventors: Dennis Giesing, Christopher Cutie
  • Methods of treatment and maintenance therapy for bladder cancer using gemcitabine
    Patent number: 10792297
    Abstract: Provided are methods of treating urothelial carcinomas of the lower tract comprising administering comprising administering gemcitabine continuously and locally to the bladder of an individual in an induction therapy and/or maintenance therapy.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: October 6, 2020
    Assignee: TARIS Biomedical LLC
    Inventors: Dennis Giesing, Christopher Cutie
  • METHOD OF TREATING LOWER TRACT UROTHELIAL CANCER
    Publication number: 20190388338
    Abstract: The present invention provides methods, devices, and kits related to treatment of urothelial carcinomas of the lower tract with antimetabolite (such as gemcitabine). In some aspects the methods, devices and kits relate to treatment of urothelial carcinomas of the lower tract with an antimetabolite (such as gemcitabine) and an immunomodulating agent.
    Type: Application
    Filed: May 5, 2017
    Publication date: December 26, 2019
    Applicant: Taris Biomedical LLC
    Inventors: Dennis GIESING, Christopher CUTIE, Purnanand SARMA, Cheryl LARRIVEE-ELKINS, Christopher SEARCY, Vikas AGARWAL
  • METHODS OF TREATMENT AND MAINTENANCE THERAPY FOR BLADDER CANCER USING GEMCITBINE
    Publication number: 20190175637
    Abstract: Provided are methods of treating urothelial carcinomas of the lower tract comprising administering comprising administering gemcitabine continuously and locally to the bladder of an individual in an induction therapy and/or maintenance therapy.
    Type: Application
    Filed: November 7, 2018
    Publication date: June 13, 2019
    Applicant: Taris Biomedical LLC
    Inventors: Dennis GIESING, Christopher CUTIE